β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life

• β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life, Mehran Karimi, Sezaneh Haghpanah, Ali T. Taher, and Maria Domenica Cappellini
  Volume 2012 (2012), Article ID 902067, 1 page
• Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial, John Porter, Donald K. Bowden, Marina Economou, Jacques Troncy, Arnold Ganser, Dany Habr, Nicolas Martin, Adam Gater, Diana Rofail, Linda Abetz-Webb, Helen Lau, and Maria Domenica Cappellini
  Volume 2012 (2012), Article ID 297641, 10 pages
• Physiopathology of Bone Modifications in -Thalassemia, Carlo Perisano, Emanuele Marzetti, Maria Silvia Spinelli, Cinzia Anna Maria Callà, Calogero Graci, and Giulio Maccauro
  Volume 2012 (2012), Article ID 320737, 5 pages
• Correlation of Oxidative Stress with Serum Trace Element Levels and Antioxidant Enzyme Status in Beta Thalassemia Major Patients: A Review of the Literature, Q. Shazia, Z. H. Mohammad, Taibur Rahman, and Hossain Uddin Shekhar
  Volume 2012 (2012), Article ID 270923, 7 pages
• Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress, Mutaz Dana, Eugenia Prus, and Eitan Fibach
  Volume 2012 (2012), Article ID 943974, 5 pages
• Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study, Nahid Ashjazadeh, Sajad Emami, Peyman Petramfar, Ehsan Yaghoubi, and Mehran Karimi
  Volume 2012 (2012), Article ID 798296, 4 pages